Lung cancer therapy may improve outcomes of metastatic brain cancer
(St. Michael's Hospital) A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St. Michael's Hospital of Unity Health Toronto and Harvard Medical School.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Cancer Therapy | Harvard | Hospitals | Lung Cancer | Neurology | Non-Small Cell Lung Cancer